The I-Mab team from L-R: CFO Jielun Zhu; President Zheru Zhang; Founder and chairman Jingwu Zang; CEO Joan Shen; and chief commercial officer Ivan Yifei Zhu

September 29, 2021 06:47 AM EDT

China

I-Mab in talks about deals, stake sale to build on $3B AbbVie alliance — Bloomberg

Amber Tong

A year after I-Mab made headlines with its $2.9 billion deal licensing a CD47 drug to AbbVie, the Chinese biotech is reportedly holding early talks …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

I-Mab in talks about deals, stake sale to build on $3B AbbVie alliance — Bloomberg

Amber Tong

Sign up to read this article for free.

Idorsia eyes layoffs, tees up Tryvio licensing deal to extend cash runway

To lead NIH, Trump taps Stanford academic and pandemic response critic Jay Bhattacharya

The Biden administration wants Medicare and Medicaid to cover GLP-1s. Will the Trump White House allow it?

Updated: Amgen obesity shot shows 20% weight loss, but dosing questions hang over readout

Acadia snaps up an essential tremor drug after field's summer setbacks

Sarepta licenses Arrowhead's RNA-based rare disease pipeline, promising big biobucks

I-Mab in talks about deals, stake sale to build on $3B Ab­b­Vie al­liance — Bloomberg

Amber Tong

Sign up to read this article for free.

more like this

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

The Biden ad­min­is­tra­tion wants Medicare and Med­ic­aid to cov­er GLP-1s. Will the Trump White House al­low it?

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

Aca­dia snaps up an es­sen­tial tremor drug af­ter field­'s sum­mer set­backs

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

I-Mab in talks about deals, stake sale to build on $3B AbbVie alliance — Bloomberg

Idorsia eyes layoffs, tees up Tryvio licensing deal to extend cash runway

To lead NIH, Trump taps Stanford academic and pandemic response critic Jay Bhattacharya

The Biden administration wants Medicare and Medicaid to cover GLP-1s. Will the Trump White House allow it?

Updated: Amgen obesity shot shows 20% weight loss, but dosing questions hang over readout

Acadia snaps up an essential tremor drug after field's summer setbacks

Sarepta licenses Arrowhead's RNA-based rare disease pipeline, promising big biobucks